International Journal of Chronic Obstructive Pulmonary Disease

Scope & Guideline

Connecting Professionals to Transform COPD Care

Introduction

Immerse yourself in the scholarly insights of International Journal of Chronic Obstructive Pulmonary Disease with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1178-2005
PublisherDOVE MEDICAL PRESS LTD
Support Open AccessYes
CountryNew Zealand
TypeJournal
Convergefrom 2006 to 2024
AbbreviationINT J CHRONIC OBSTR / Int. J. Chronic Obstr. Pulm. Dis.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND

Aims and Scopes

The International Journal of Chronic Obstructive Pulmonary Disease primarily focuses on advancing research related to chronic obstructive pulmonary disease (COPD), with a strong emphasis on clinical studies, epidemiology, and innovative therapeutic approaches.
  1. Clinical Management and Treatment Strategies:
    The journal publishes studies that explore various management strategies for COPD, including pharmacological treatments, inhalation therapies, and non-pharmacological interventions such as pulmonary rehabilitation.
  2. Epidemiology and Risk Factors:
    Research focusing on the prevalence, risk factors, and comorbidities associated with COPD is a key area of interest, providing valuable insights into the disease's impact on diverse populations.
  3. Pathophysiology and Mechanisms:
    The journal emphasizes studies that investigate the underlying mechanisms of COPD, including inflammatory pathways, genetic factors, and the role of the microbiome in disease progression.
  4. Quality of Life and Patient-Centered Approaches:
    Articles addressing the quality of life in COPD patients, including psychological aspects such as anxiety and depression, and the effectiveness of patient education and self-management strategies are commonly featured.
  5. Innovative Technologies and Interventions:
    The journal is open to research on new technologies, such as telemedicine, digital health solutions, and novel pharmacological agents that aim to improve patient outcomes and disease management.
Recent publications in the International Journal of Chronic Obstructive Pulmonary Disease indicate several emerging themes that are gaining traction within the field.
  1. Integration of Digital Health Solutions:
    The rise of digital health technologies, including telehealth and mobile health applications, is becoming a central theme, reflecting a shift towards remote monitoring and management of COPD.
  2. Comorbidity Research:
    There is an increasing focus on the interplay between COPD and other chronic conditions, such as cardiovascular diseases and metabolic syndromes, highlighting the importance of integrated care approaches.
  3. Patient-Centered Outcomes and Quality of Life:
    Research emphasizing patient-reported outcomes, quality of life assessments, and psychosocial factors in COPD management is trending, indicating a growing recognition of the holistic nature of care.
  4. Biomarkers and Personalized Medicine:
    Studies exploring biomarkers for diagnosis, prognosis, and treatment responses are on the rise, representing a shift towards personalized medicine approaches in COPD management.
  5. Environmental and Lifestyle Factors:
    Emerging research is increasingly addressing the impact of environmental exposures, dietary habits, and lifestyle modifications on COPD development and management.

Declining or Waning

As the field of COPD research evolves, certain themes have shown a decline in focus within the journal's recent publications.
  1. Traditional Pharmacological Therapies:
    There has been a noticeable reduction in studies focused solely on traditional pharmacological therapies, such as oral corticosteroids, as newer therapeutic approaches gain prominence.
  2. Surgery and Invasive Procedures:
    Research related to surgical interventions for COPD, such as lung volume reduction surgery, appears to have decreased, likely due to a growing preference for less invasive management options.
  3. Basic Science Research:
    While fundamental research into COPD pathophysiology remains important, the journal has seen fewer basic science studies compared to clinical and translational research, reflecting a shift towards more applied investigations.

Similar Journals

Minerva Respiratory Medicine

Connecting research and practice in pulmonary health.
Publisher: EDIZIONI MINERVA MEDICAISSN: 2784-8477Frequency: 4 issues/year

Minerva Respiratory Medicine is a prominent academic journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by EDIZIONI MINERVA MEDICA in Italy, this journal provides a vital platform for the dissemination of innovative research, clinical studies, and review articles that address the complexities of respiratory health. With an ISSN of 2784-8477 and an E-ISSN of 2724-6493, it serves as an open-access resource, allowing researchers, healthcare professionals, and students access to invaluable information without barriers. The journal is categorized in the fourth quartile of the 2023 rankings in the field of pulmonary and respiratory medicine, indicating its emerging role in the academic landscape. Despite its nascent status—converging from 2021 to 2024—Minerva Respiratory Medicine is committed to enhancing knowledge and practice in respiratory care, focusing on both innovative therapies and traditional approaches. With its aim to foster collaboration and communication among professionals in the field, this journal is an essential resource for those passionate about improving respiratory health outcomes.

Jornal Brasileiro de Pneumologia

Championing excellence in pulmonary and respiratory research.
Publisher: SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIAISSN: 1806-3713Frequency: 6 issues/year

Jornal Brasileiro de Pneumologia is a pivotal open-access journal in the field of Pulmonary and Respiratory Medicine, published by SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA. Established in 2004, this esteemed publication has become a significant platform for researchers, health professionals, and students in Brazil and beyond, facilitating the exchange of innovative ideas and vital research findings. The journal is indexed in Scopus and is recognized in the 2023 category quartiles as Q3, ranking 86 out of 155 in its field with a corresponding 44th percentile. This reflects its growing influence and commitment to advancing knowledge concerning respiratory health. With a mission to disseminate high-quality research, the journal aims to foster advancements in clinical practice and improve outcomes in pulmonary diseases, making it an essential resource for those dedicated to enhancing the quality of care in respiratory medicine. For those seeking comprehensive access to critical studies and reviews in this domain, the Jornal Brasileiro de Pneumologia remains an invaluable asset.

RESPIRATORY MEDICINE

Unraveling Complexities of Respiratory Conditions
Publisher: W B SAUNDERS CO LTDISSN: 0954-6111Frequency: 12 issues/year

Respiratory Medicine is a leading journal in the field of pulmonary and respiratory medicine, dedicated to advancing knowledge and research from 1989 to 2024. Published by W B Saunders Co Ltd, this esteemed journal is recognized for its high impact, reflected in its Q1 quartile ranking in 2023 within the category of Pulmonary and Respiratory Medicine and its impressive Scopus ranking of 27 out of 155 journals, placing it in the 82nd percentile. With a focus on publishing groundbreaking research, comprehensive reviews, and innovative practices, Respiratory Medicine serves as an essential resource for health professionals, researchers, and students aiming to improve patient outcomes and understand complex respiratory conditions. While the journal is not Open Access, its contributions to the scientific community are invaluable, providing insights that drive both academic and clinical advancements in respiratory health.

Annals of the American Thoracic Society

Pioneering the path in pulmonary and respiratory advancements.
Publisher: AMER THORACIC SOCISSN: 1546-3222Frequency: 12 issues/year

Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.

Chronic Obstructive Pulmonary Diseases-Journal of the COPD Foundation

Connecting professionals with groundbreaking COPD studies.
Publisher: COPD FOUNDATIONISSN: 2372-952XFrequency: 4 issues/year

Chronic Obstructive Pulmonary Diseases - Journal of the COPD Foundation, published by the esteemed COPD Foundation, serves as a vital platform for advancing research in the field of pulmonary and respiratory medicine. With an ISSN of 2372-952X, this journal emphasizes the exploration and dissemination of knowledge related to chronic obstructive pulmonary disease (COPD) while addressing broader topics in respiratory health. Recognized within the Q2 category of the 2023 *Scopus* rankings and positioned at the 47th percentile in its field, the journal showcases innovative studies, clinical insights, and evidence-based practices crucial for professionals, researchers, and students alike. Although operating as a traditional publication, it seeks to provide immediate access to groundbreaking research on the prevention and management of COPD, facilitating improved patient outcomes. As it continues to expand its influence since its convergence in 2018, this journal is dedicated to bridging gaps in pulmonary medicine, making it an indispensable resource for the global respiratory health community.

Thoracic Research and Practice

Pioneering Discoveries in Pulmonary and Respiratory Medicine
Publisher: AVESISSN: Frequency: 6 issues/year

Thoracic Research and Practice is an emerging open access journal published by AVES that aims to advance knowledge in the field of pulmonary and respiratory medicine. Launched in 2022, this journal aspires to provide a platform for innovative research, clinical practices, and advancements in thoracic health. With an E-ISSN of 2979-9139, it caters to a global audience while based in Turkey. Although it currently holds a Q4 category in the 2023 ranking within its field, the journal is dedicated to improving its standing through the inclusion of high-quality, original articles, systematic reviews, and case studies. As it converges years from 2023 to 2024, Thoracic Research and Practice invites researchers, professionals, and students to contribute valuable insights that aim to enhance patient outcomes and propel further exploration in this critical area of medicine.

Pulmonary Circulation

Exploring breakthroughs in respiratory medicine.
Publisher: WILEYISSN: 2045-8932Frequency: 4 issues/year

Pulmonary Circulation is a leading open-access journal published by Wiley, focused on advancing the field of pulmonary and respiratory medicine. Established in 2011, the journal has garnered a prestigious reputation, achieving a Q2 ranking in 2023 among its category and ranking #70 out of 155 in Scopus within the specialty of Medicine – Pulmonary and Respiratory Medicine, reflecting its growing influence and relevance in the scientific community. With its commitment to delivering high-quality, peer-reviewed research, Pulmonary Circulation serves as a vital resource for researchers, clinicians, and students seeking to explore innovative ideas and findings in lung health, pulmonary vascular diseases, and therapeutic approaches. The journal has been open access since 2017, ensuring that groundbreaking research is accessible to a wider audience, thus promoting collaboration and knowledge exchange in this dynamic field. Located in the heart of the United States at 111 River St, Hoboken, NJ 07030-5774, the journal is dedicated to fostering advancements in pulmonary health and addressing real-world challenges facing patients globally.

COPD-Journal of Chronic Obstructive Pulmonary Disease

Enhancing access to vital COPD research.
Publisher: TAYLOR & FRANCIS INCISSN: 1541-2555Frequency: 6 issues/year

COPD - Journal of Chronic Obstructive Pulmonary Disease is a premier peer-reviewed journal published by Taylor & Francis Inc. that focuses on the latest advancements in the understanding, diagnosis, and treatment of chronic obstructive pulmonary disease (COPD). As an Open Access journal since 2022, it enhances availability and dissemination of groundbreaking research, allowing researchers, healthcare professionals, and students to access vital information without barriers. The journal has established itself as a significant resource in pulmonary and respiratory medicine, boasting a commendable Q2 ranking in both medicine and specialty areas as of 2023, with an impressive Scopus rank of 66 out of 155. By bridging the gap between scientific exploration and clinical application, COPD aims to foster innovative approaches to managing this prevalent condition, making it an essential publication for those dedicated to improving patient care and advancing respiratory health.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Innovating the future of respiratory physiology.
Publisher: AMER PHYSIOLOGICAL SOCISSN: 1040-0605Frequency: 12 issues/year

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, published by the American Physiological Society, stands as a prominent peer-reviewed journal dedicated to advancing the field of lung cellular and molecular physiology. With an impressive impact factor, the journal serves as a crucial platform for disseminating high-quality research focused on the intricate mechanisms underlying pulmonary function and disease. Established in 1989, this journal has consistently ranked within the top quartiles across various categories, including Q1 in Physiology and Pulmonary and Respiratory Medicine, highlighting its significance in the scientific community. The journal covers a wide scope of topics pertinent to cell biology and physiology, catering to the needs of researchers, professionals, and students seeking to explore and contribute to this vital area of study. Although currently not offering open access, it provides comprehensive access options for subscribers, ensuring that vital research is communicated effectively to the global scientific community. With a commitment to fostering innovation and inspiring future studies, the AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY remains an essential resource for those engaged in lung research.

Annals of Physical and Rehabilitation Medicine

Exploring New Frontiers in Physical Medicine and Recovery
Publisher: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIERISSN: 1877-0657Frequency: 6 issues/year

Annals of Physical and Rehabilitation Medicine, published by Elsevier France-Editions Scientifiques Medicales Elsevier, stands as a leading peer-reviewed journal in the fields of Orthopedics and Rehabilitation. With its ISSN 1877-0657 and E-ISSN 1877-0665, this esteemed journal is known for its high-quality research articles that significantly influence clinical practices and advancements in rehabilitation medicine. Recognized for its impact, the journal is categorized in the Q1 quartiles for both Orthopedics and Sports Medicine as well as Rehabilitation disciplines. According to the Scopus rankings, it ranks #5 out of 161 in Rehabilitation and #20 out of 321 in Orthopedics and Sports Medicine, illustrating its critical role in shaping the future of these fields with a remarkable 97th and 93rd percentile standing respectively. With a commitment to excellence, the journal publishes innovative research that addresses the evolving needs of both practitioners and patients, making it an essential resource for researchers, professionals, and students dedicated to improving rehabilitation practices. The journal operates under conventional access options, ensuring that its groundbreaking findings remain accessible to a wide audience.